UY27380A1 - Compuestos de heteroarilo bicíclicos fusionados sustituidos con heteroarilo como ligandos del receptor gabaa - Google Patents
Compuestos de heteroarilo bicíclicos fusionados sustituidos con heteroarilo como ligandos del receptor gabaaInfo
- Publication number
- UY27380A1 UY27380A1 UY27380A UY27380A UY27380A1 UY 27380 A1 UY27380 A1 UY 27380A1 UY 27380 A UY27380 A UY 27380A UY 27380 A UY27380 A UY 27380A UY 27380 A1 UY27380 A1 UY 27380A1
- Authority
- UY
- Uruguay
- Prior art keywords
- compounds
- gabaa
- heteroarilo
- heteroaril
- fusioned
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Compuestos de heteroarilo fusionados sustituidos con heteroarilo de fórmula I, como imidazopiridinas, imidazopirazinas, imidazopiridazinas, imidazopirimidinas e imidazotiazoles sustituidos con heteroarilo, y más específicamente con compuestos que se enlazan con elevada selectividad y afinidad al emplazamiento de benzodiazepina de los receptores GABA. Composiciones farmacéuticas comprendiendo dichos compuestos y con su uso para tratamiento de enfermedades del sistema nervioso central (CNS). Uso de compuestos referidos así como con los relacionados en combinación con uno o más de otros agentes con el fin de potenciar los efectos de otros agentes para el CNS. Uso de ellos como sondas para ubicación de los receptores GABAa en secciones de tejido.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30553301P | 2001-07-13 | 2001-07-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY27380A1 true UY27380A1 (es) | 2003-02-28 |
Family
ID=23181185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY27380A UY27380A1 (es) | 2001-07-13 | 2002-07-12 | Compuestos de heteroarilo bicíclicos fusionados sustituidos con heteroarilo como ligandos del receptor gabaa |
Country Status (16)
Country | Link |
---|---|
US (2) | US6936617B2 (es) |
EP (1) | EP1406906A1 (es) |
JP (1) | JP2005505518A (es) |
KR (1) | KR20040015356A (es) |
CN (2) | CN101220027A (es) |
AR (1) | AR036168A1 (es) |
BR (1) | BR0211124A (es) |
CA (1) | CA2453554A1 (es) |
GT (1) | GT200200148A (es) |
IL (1) | IL159811A0 (es) |
MX (1) | MXPA04000372A (es) |
NZ (1) | NZ530992A (es) |
PA (1) | PA8550401A1 (es) |
PE (1) | PE20030292A1 (es) |
UY (1) | UY27380A1 (es) |
WO (1) | WO2003006471A1 (es) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7482366B2 (en) * | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
DE60335635D1 (de) | 2002-05-22 | 2011-02-17 | Amgen Inc | Aminopyrimidin-derivate zur verwendung als vanilloid-rezeptor-liganden zur behandlung von schmerzen |
TW200410945A (en) | 2002-08-08 | 2004-07-01 | Amgen Inc | Vanilloid receptor ligands and their use in treatments" |
UA80295C2 (en) | 2002-09-06 | 2007-09-10 | Biogen Inc | Pyrazolopyridines and using the same |
DE10247271A1 (de) * | 2002-10-10 | 2004-08-26 | Grünenthal GmbH | Substituierte C-Imidazo[1,2-a]pyridin-3-yle |
KR20060098425A (ko) * | 2003-07-25 | 2006-09-18 | 뉴로젠 코포레이션 | 이미다조-피리미딘 및 트리아졸로-피리미딘: 벤조디아제핀수용체 리간드 |
ZA200600037B (en) * | 2003-07-25 | 2007-04-25 | Neurogen Corp | Imidazo-pyrimidines and triazolo-pyrimidines: Benzodiazepine receptor ligands |
EP1880998A1 (en) * | 2003-07-25 | 2008-01-23 | Neurogen Corporation | Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
MY139645A (en) | 2004-02-11 | 2009-10-30 | Amgen Inc | Vanilloid receptor ligands and their use in treatments |
JP2007522233A (ja) | 2004-02-11 | 2007-08-09 | アムジエン・インコーポレーテツド | バニロイド受容体リガンド及び治療におけるそれらの使用 |
WO2005080355A1 (en) * | 2004-02-12 | 2005-09-01 | Neurogen Corporation | Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands |
US20080004269A1 (en) * | 2004-11-04 | 2008-01-03 | Yuelian Xu | Pyrazolylmethy Heteroaryl Derivatives |
US7301022B2 (en) | 2005-02-15 | 2007-11-27 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
US20070155738A1 (en) | 2005-05-20 | 2007-07-05 | Alantos Pharmaceuticals, Inc. | Heterobicyclic metalloprotease inhibitors |
EP1928237A4 (en) * | 2005-09-02 | 2011-03-09 | Abbott Lab | NEW HETEROCYCLES BASED ON IMIDAZO |
US7750000B2 (en) * | 2005-09-02 | 2010-07-06 | Bayer Schering Pharma Ag | Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments |
WO2007075869A2 (en) * | 2005-12-23 | 2007-07-05 | Ariad Pharmaceuticals, Inc. | Bicyclic heteroaryl compounds |
EP2023933A4 (en) * | 2006-05-08 | 2011-02-23 | Ariad Pharma Inc | HETEROARYL ACETYLENE COMPOUNDS |
CA2650273C (en) * | 2006-05-08 | 2016-06-07 | Ariad Pharmaceuticals, Inc. | Monocyclic heteroaryl compounds |
CN101652069A (zh) * | 2007-03-27 | 2010-02-17 | 艾博特公司 | 新的基于咪唑并的杂环化合物 |
EP1974729A1 (en) | 2007-03-28 | 2008-10-01 | Santhera Pharmaceuticals (Schweiz) AG | Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists |
EP2072516A1 (en) * | 2007-12-21 | 2009-06-24 | Santhera Pharmaceuticals (Schweiz) AG | Substituted imidazopyridine derivates as Melancortin-4 receptor antagonists |
US8263630B2 (en) | 2008-02-12 | 2012-09-11 | Bristol-Myers Squibb Company | 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type I inhibitors |
US8846664B2 (en) | 2008-11-12 | 2014-09-30 | Ariad Pharmaceuticals, Inc. | Pyrazinopyrazines and derivatives as kinase inhibitors |
US10206921B2 (en) | 2009-06-03 | 2019-02-19 | The Regents Of The University Of California | Methods and compositions for treating a subject for central nervous system (CNS) injury |
EP2298296A1 (en) * | 2009-08-25 | 2011-03-23 | CNRS Centre National De La Recherche Scientifique | Composition and method for treating cognitive impairments in down syndrome subjects |
ES2651296T3 (es) | 2009-10-30 | 2018-01-25 | Janssen Pharmaceutica, N.V. | Derivados de imidazo[1,2-b]piridacina y su uso como inhibidores de PDE10 |
AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
CA2837818A1 (en) * | 2010-06-03 | 2011-12-08 | The Regents Of The University Of California | Methods and compositions for treating a subject for central nervous system (cns) injury |
KR101034040B1 (ko) * | 2010-08-16 | 2011-05-16 | 정동영 | 백업트랙터 |
WO2013000924A1 (en) | 2011-06-27 | 2013-01-03 | Janssen Pharmaceutica Nv | 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES |
US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
EP2863909B1 (en) | 2012-06-26 | 2020-11-04 | Janssen Pharmaceutica N.V. | Combinations comprising 4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline compounds as pde 2 inhibitors and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders |
CN104411314B (zh) | 2012-07-09 | 2017-10-20 | 詹森药业有限公司 | 磷酸二酯酶10的抑制剂 |
CA3022250A1 (en) | 2012-12-12 | 2014-06-12 | Ariad Pharmaceuticals, Inc. | Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride |
US9527835B2 (en) | 2014-02-13 | 2016-12-27 | Incyte Corporation | Cyclopropylamines as LSD1 inhibitors |
ES2760261T3 (es) | 2014-02-13 | 2020-05-13 | Incyte Corp | Ciclopropilaminas como inhibidores de LSD1 |
HUE045725T2 (hu) | 2014-02-13 | 2020-01-28 | Incyte Corp | Ciklopropilaminok mint LSD1 inhibitorok |
ES2672797T3 (es) | 2014-02-13 | 2018-06-18 | Incyte Corporation | Ciclopropilaminas como inhibidores de LSD1 |
WO2016007736A1 (en) | 2014-07-10 | 2016-01-14 | Incyte Corporation | Imidazopyrazines as lsd1 inhibitors |
WO2016007722A1 (en) | 2014-07-10 | 2016-01-14 | Incyte Corporation | Triazolopyridines and triazolopyrazines as lsd1 inhibitors |
US9758523B2 (en) | 2014-07-10 | 2017-09-12 | Incyte Corporation | Triazolopyridines and triazolopyrazines as LSD1 inhibitors |
US9695168B2 (en) | 2014-07-10 | 2017-07-04 | Incyte Corporation | Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors |
EP3240785B1 (en) | 2014-12-29 | 2021-07-07 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Small molecule inhibitors of lactate dehydrogenase and methods of use thereof |
MX2017012699A (es) | 2015-04-03 | 2018-02-09 | Incyte Corp | Compuestos heterociclicos como inhibidores de demetilasa 1 especifica de lisina (lsd1). |
KR20180051523A (ko) | 2015-08-12 | 2018-05-16 | 인사이트 코포레이션 | Lsd1 저해제의 염 |
SG11201809299QA (en) | 2016-04-22 | 2018-11-29 | Incyte Corp | Formulations of an lsd1 inhibitor |
WO2020047198A1 (en) | 2018-08-31 | 2020-03-05 | Incyte Corporation | Salts of an lsd1 inhibitor and processes for preparing the same |
US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
CN111662270A (zh) * | 2019-03-05 | 2020-09-15 | 中国医学科学院药物研究所 | 碘同位素标记苄苯醚衍生物、及其制法和药物组合物与用途 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989001333A1 (en) * | 1987-08-07 | 1989-02-23 | The Australian National University | IMIDAZO[1,2-b]PYRIDAZINES |
WO1996034866A1 (en) * | 1995-05-01 | 1996-11-07 | Fujisawa Pharmaceutical Co., Ltd. | Imidazo 1,2-a pyridine and imidazo 1,2-a pyridezine derivatives and their use as bone resorption inhibitors |
GB9801538D0 (en) | 1998-01-23 | 1998-03-25 | Merck Sharp & Dohme | Pharmaceutical product |
GB9805559D0 (en) | 1998-03-16 | 1998-05-13 | Merck Sharp & Dohme | A combination of therapeutic agents |
GB9805561D0 (en) | 1998-03-16 | 1998-05-13 | Merck Sharp & Dohme | A combination of therapeutic agents |
GB9805557D0 (en) | 1998-03-16 | 1998-05-13 | Merck Sharp & Dohme | A combination of therapeutic agents |
US6271241B1 (en) | 1999-04-02 | 2001-08-07 | Neurogen Corporation | Cycloalkyl and aryl fused aminoalkyl-imidazole derivatives: modulators and GLP-1 receptors |
US6380210B1 (en) | 1999-04-02 | 2002-04-30 | Neurogen Corporation | Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
US6358949B1 (en) | 1999-04-02 | 2002-03-19 | Neurogen Corporation | Aryl and hetroaryl fused aminoalkyl-imidazole derivatives: selective modulators of bradykinin B2 receptors |
AU2001236471A1 (en) | 2000-01-18 | 2001-07-31 | Neurogen Corporation | Imidazopyridines and related azacyclic derivatives as selective modulators of bradykinin b2 receptors |
AU2001270297A1 (en) * | 2000-06-30 | 2002-01-14 | Neurogen Corporation | 2-phenylimidazo(1,2-a)pyridine derivatives: a new class of gaba brain receptor ligands |
PA8535601A1 (es) | 2000-12-21 | 2002-11-28 | Pfizer | Derivados benzimidazol y piridilimidazol como ligandos para gabaa |
-
2001
- 2001-07-12 IL IL15981101A patent/IL159811A0/xx unknown
-
2002
- 2002-07-11 GT GT200200148A patent/GT200200148A/es unknown
- 2002-07-12 BR BR0211124-1A patent/BR0211124A/pt not_active IP Right Cessation
- 2002-07-12 CN CNA2008100019411A patent/CN101220027A/zh active Pending
- 2002-07-12 PE PE2002000626A patent/PE20030292A1/es not_active Application Discontinuation
- 2002-07-12 UY UY27380A patent/UY27380A1/es not_active Application Discontinuation
- 2002-07-12 CN CNB028166965A patent/CN100369912C/zh not_active Expired - Fee Related
- 2002-07-12 AR ARP020102628A patent/AR036168A1/es unknown
- 2002-07-12 WO PCT/US2002/022130 patent/WO2003006471A1/en active IP Right Grant
- 2002-07-12 MX MXPA04000372A patent/MXPA04000372A/es active IP Right Grant
- 2002-07-12 US US10/194,852 patent/US6936617B2/en not_active Expired - Fee Related
- 2002-07-12 CA CA002453554A patent/CA2453554A1/en not_active Abandoned
- 2002-07-12 JP JP2003512241A patent/JP2005505518A/ja active Pending
- 2002-07-12 PA PA20028550401A patent/PA8550401A1/es unknown
- 2002-07-12 NZ NZ530992A patent/NZ530992A/en unknown
- 2002-07-12 EP EP02749983A patent/EP1406906A1/en not_active Withdrawn
- 2002-07-12 KR KR10-2004-7000563A patent/KR20040015356A/ko not_active Application Discontinuation
-
2005
- 2005-08-29 US US11/214,345 patent/US20060014746A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MXPA04000372A (es) | 2004-07-23 |
CN100369912C (zh) | 2008-02-20 |
US20060014746A1 (en) | 2006-01-19 |
CN101220027A (zh) | 2008-07-16 |
WO2003006471A1 (en) | 2003-01-23 |
NZ530992A (en) | 2005-06-24 |
AR036168A1 (es) | 2004-08-18 |
CA2453554A1 (en) | 2003-01-23 |
CN1553916A (zh) | 2004-12-08 |
PA8550401A1 (es) | 2004-02-07 |
IL159811A0 (en) | 2004-06-20 |
PE20030292A1 (es) | 2003-04-03 |
BR0211124A (pt) | 2004-06-29 |
US6936617B2 (en) | 2005-08-30 |
US20030207885A1 (en) | 2003-11-06 |
JP2005505518A (ja) | 2005-02-24 |
KR20040015356A (ko) | 2004-02-18 |
EP1406906A1 (en) | 2004-04-14 |
GT200200148A (es) | 2003-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY27380A1 (es) | Compuestos de heteroarilo bicíclicos fusionados sustituidos con heteroarilo como ligandos del receptor gabaa | |
ECSP034656A (es) | Derivados benzimidazol y piridilimidazol como ligandos para gabaa | |
UY30080A1 (es) | Compuestos de heteroarilo biciclicos como inhibidores de pde10 | |
ECSP055699A (es) | Indazoles, benzotiazoles y benzoisotiazoles, y su preparacion y usos | |
BRPI0519760A2 (pt) | derivados de pirrolidila de compostos heteroaromÁticos como inibidores de fosfodiesterasse | |
WO2001034603A3 (en) | Bicyclic and tricyclic heteroaromatic compounds | |
ATE424402T1 (de) | Imidazopyridinverbindungen | |
SV2008002365A (es) | Compuestos de quinolina heteroaromaticos ref. pc32593a | |
CR8847A (es) | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y usos de los mismos | |
CL2007001555A1 (es) | Compuestos derivados de 4-amino-pirido[3,2-e]pirazinas; inhibidores de fosfodiesterasa 10 (pde10); procedimeinto de preparacion; composicion framaceutica; combinacion farmaceutica, y sus uso en el tratamiento de trastornos neurologicos y psiquiatricos, tales como esquizofrenia y otros trastornos psicoticos. | |
PA8675701A1 (es) | Nuevos derivados del fluoreno, composiciones que los contienen y su utilización | |
UY28970A1 (es) | Compuestos moduladores de la actividad de c-kit y usos de los mismos | |
EA201270498A1 (ru) | 8-этил-6-(арил)пиридо[2,3-d]пиримидин-7(8h)-оны для лечения заболеваний цнс | |
EA200400860A1 (ru) | 2-(ПИРИДИН-2-ИЛАМИНО)-ПИРИДО[2,3-d]ПИРИМИДИН-7-ОНЫ | |
ATE280172T1 (de) | Isomere kondensierte pyrrolocarbazole und isoindolone | |
UY27079A1 (es) | Procedimiento para la preparación de un anticolinérgico | |
ECSP045473A (es) | Derivados de 1-(aminoalquil)-3-sulfonilindol y 1-aminoalquil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6 | |
CU23464B7 (es) | (1,8)naftidirin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia | |
ECSP034428A (es) | Ciclopentanoindoles, composiciones conteniendo tales compuestos y su uso | |
HN2002000365A (es) | Lactamas como antagonistas de taquiquininas | |
GT200500319A (es) | Algunos metabolitos derivados de [1,4]diazepino[6,7,1-ij]quinolina y metodos para la preparacion y usos de los mismos. | |
UY27232A1 (es) | Nuevos compuestos de dihidropirimidina ciano substituidos y su uso para tratar padecimientos | |
UY26601A1 (es) | Antagonistas de los receptores de il-8 | |
PA8550001A1 (es) | Derivados de acido cicloalquilpirrol-3-carboxilico y derivados de acido heterocicloalquilpirrol-3-carboxilico | |
DOP2002000430A (es) | Derivados de acido cicloalquilprirrol-3-carboxilico y derivados de acido heterocicloalquilpirrol-3-carboxilico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20141217 |